Myriad Genetics Inc (MYGN)

Capital Expenditure

-$2.10M

Quarterly · Period ending: · USD

MYGN logo

MYGN Capital Expenditure

Latest reported-$2.10M
MYGN Quarterly CapEx (-$2.20M → -$2.10M)
High-resolution chart · PNG

MYGN capital expenditure history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Capital Expenditure — Quarterly (USD)
Period endingCapital Expenditure (USD)
-2,100,000
-5,400,000
-6,000,000
-2,800,000
-6,900,000
-5,300,000
-5,900,000
-3,500,000
-5,200,000
-8,600,000
-13,500,000
-17,500,000
-18,800,000
-23,500,000
-14,600,000
-17,700,000
-6,700,000
-6,300,000
-3,400,000
-3,000,000
-4,500,000
-7,100,000
-6,300,000
-1,500,000
-2,400,000
-3,000,000
-3,400,000
-1,400,000
-1,400,000
-3,100,000
-2,800,000
-1,300,000
-1,800,000
-2,900,000
-2,100,000
-1,600,000
-700,000
-1,500,000
-2,400,000
-1,500,000
-2,200,000
-700,000
-1,100,000
-1,000,000
-1,995,000
-4,400,000
-6,000,000
-11,500,000
-4,618,000
-1,555,000
-2,833,000
-5,265,000
-2,791,000
-1,574,000
-4,547,000
-2,461,000
-2,092,000
-2,000,000
-3,857,000
-2,109,000
-2,510,000
-1,758,000
-1,065,000
-1,959,000
0
-1,248,000
-4,343,000
-1,577,000
0
0
-2,575,000
-934,000
-3,906,000
-1,613,000
-4,874,000
-3,282,000
-2,742,000
-1,393,000
-4,785,000
-2,480,000
-1,834,000
-2,594,000
-2,338,000
-914,000
-4,294,000
-716,000
-917,000
-809,000
-1,007,000
-347,000
-1,086,000
-1,443,000
-1,649,000
-910,000
-2,457,000
-3,020,000
-4,235,254
-719,915
-1,122,573
-775,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.